INSERM, IAME, Université de Paris, Paris, France.
AP-HP Nord, Emergency Department, Bichat-Claude Bernard University Hospital, Paris, France.
PLoS One. 2020 Dec 3;15(12):e0243261. doi: 10.1371/journal.pone.0243261. eCollection 2020.
Rapid identification of patients with high suspicion of COVID-19 will become a challenge with the co-circulation of multiple respiratory viruses (RVs). We have identified clinical or biological characteristics to help distinguish SARS-CoV-2 from other RVs.
We used a prospective cohort including all consecutive patients admitted through the emergency department's (ED) and presenting respiratory symptoms from November 2019 to April 2020. Patients were tested for RV using multiplex polymerase chain reaction (mPCR) and SARS-CoV-2 RT-PCR.
203/508 patients were positive for an RV during the non-SARS-CoV-2 epidemic period (November to February), and 268/596 patients were SARS-CoV-2 positive during the SARS-CoV-2 epidemic (March to April). Younger age, male gender, fever, absence of expectoration and absence of chronic lung disease were statistically associated with SARS-CoV-2 detection. Combining these variables allowed for the distinguishing of SARS-CoV-2 infections with 83, 65, 75 and 76% sensitivity, specificity, PPV and NPV, respectively.
Patients' characteristics associated with a positive PCR are common between SARS-CoV-2 and other RVs, but a simple discrimination of strong SARS-CoV-2 suspicion with a limited set of clinical features seems possible. Such scoring could be useful but has to be prospectively evaluated and will not eliminate the need for rapid PCR assays.
随着多种呼吸道病毒(RVs)的共同传播,快速识别高度疑似 COVID-19 的患者将成为一项挑战。我们已经确定了一些临床或生物学特征,可以帮助区分 SARS-CoV-2 和其他 RVs。
我们使用了一项前瞻性队列研究,纳入了 2019 年 11 月至 2020 年 4 月期间因呼吸道症状通过急诊科就诊的所有连续患者。使用多重聚合酶链反应(mPCR)和 SARS-CoV-2 RT-PCR 检测 RV。
在非 SARS-CoV-2 流行期间(11 月至 2 月),508 例患者中有 203 例 RV 阳性,在 SARS-CoV-2 流行期间(3 月至 4 月),596 例患者中有 268 例 SARS-CoV-2 阳性。年龄较小、男性、发热、无咳痰和无慢性肺部疾病与 SARS-CoV-2 检测呈阳性相关。这些变量的组合可以分别以 83%、65%、75%和 76%的敏感性、特异性、PPV 和 NPV 来区分 SARS-CoV-2 感染。
与 SARS-CoV-2 和其他 RV 相关的 PCR 阳性患者特征是常见的,但使用有限的临床特征来简单地区分强烈的 SARS-CoV-2 怀疑似乎是可能的。这种评分可能有用,但需要前瞻性评估,并且不会消除对快速 PCR 检测的需求。